31 followers
Intravitreal injection of ranibizumab can produce early changes in OCT parameters (reduced central retinal thickness, volume, and total retinal volume) and improve perceived visual quality of patients with wet AMD as early as day 1. https://t.co/Nkx1AaFl8W